Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by Pareto8020on Sep 07, 2023 11:00am
242 Views
Post# 35624059

Sirona……what’s new?

Sirona……what’s new?Okay it has been a year + a quarter now since you signed the big blockbuster deal that was supposed to catapult SBM to new levels and be a watershed event.

So Allergan with all its resources hasn't moved the product to the verge of release yet?  SBM hasn't received any milestones or other payments yet so the royalties better be ginormous.  The fact they opted for next to no upfront payment while their coffers were running on fumes is still mind boggling and at any other company would have resulted in heads rolling.  Not at Sirona - Howie even convinced the board (stacked with him and his allies) this was a good idea.

I so can't wait for this company to be bought out and put us shareholders out of our misery.  Great science deplorable management.  That should be their new tag line.
<< Previous
Bullboard Posts
Next >>